CD47 and neoplasm: Moreover, anti-CD47 treatment reinvigorate effector T cells in head and neck squamous cell carcinoma mouse model and alters tumor microenvironment via reducing the infiltration of Tregs and myeloid-derived suppressor cells (MDSCs) and decrease the suppressive function of MDSCs (61).